Combination Therapy With Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Older Patients With Type 2 Diabetes: A Real-World Evidence Study

2019 ◽  
Vol 43 (3) ◽  
pp. 186-192 ◽  
Author(s):  
Juana Carretero Gómez ◽  
José Carlos Arévalo Lorido ◽  
Ricardo Gómez Huelgas ◽  
Dolores García de Lucas ◽  
Lourdes Mateos Polo ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Combination Therapy ◽  
Real World ◽  
Older Patients ◽  
Receptor Agonists ◽  
Sodium Glucose Cotransporter ◽  
Real World Evidence ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1

Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta‐analysis

2020 ◽  
Vol 22 (10) ◽  
pp. 1857-1868 ◽  
Author(s):  
Chrysanthi Mantsiou ◽  
Thomas Karagiannis ◽  
Panagiota Kakotrichi ◽  
Konstantinos Malandris ◽  
Ioannis Avgerinos ◽  
...  
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Combination Therapy ◽  
Meta Analysis ◽  
Receptor Agonists ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1
Sign in / Sign up

Export Citation Format

Share Document